Vistra: Q3 Net Income Rises To $1.14 Billion And 2027 Guidance Is Initiated

Vistra reported Q3 2026 net income of $1.14B, up from $652M a year earlier, with revenue increasing to $6.35B. Adjusted EBITDA rose over 50% to $2.38B. The company raised 2026 EBITDA guidance to $7.1B-$7.5B and initiated 2027 guidance of $7.7B-$8.5B, citing strong operational performance and hedging effects.

Original reporting
Published Nov 11, 2026, 12:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 2:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Vistra: Q3 Net Income Rises To $1.14 Billion And 2027 Guidance Is Initiated — source image
Decision brief

The 30-second read

$VSTBullishMed
01

Why it matters

The key tradable items are the raised and narrowed 2026 adjusted EBITDA guidance and the newly initiated 2027 adjusted EBITDA range, alongside reported Q3 operating performance and liquidity.

02

Market read

A guidance reset with a new out-year range can drive re-rating of forward cash flow expectations and capital-return outlook, with hedging effects as the main uncertainty.

03

What to watch

Liquidity and capital flexibility are cited, but traders may still stress-test assumptions behind adjusted free cash flow before growth and the sustainability of summer demand strength.

Relevance 9/10Novelty 8/10Timing: post-market earnings and guidance update, actionable for next-session positioning

Background

Vistra combines integrated retail and generation operations and uses hedging to manage commodity-market volatility.

Company-level read

Ticker impact

$VSTBullishMedium confidence
Context

Vistra reported Q3 2026 net income of $1.14B and raised/narrowed 2026 adjusted EBITDA guidance, while initiating 2027 adjusted EBITDA guidance.

Expected impact

Likely upward bias as the market reprices forward EBITDA and capital-return capacity, tempered by scrutiny of hedging-driven non-GAAP adjustments.

Evidence & confidence

The article provides fresh, company-specific guidance actions (2026 midpoint raised, range narrowed, and 2027 range initiated) plus detailed operating/EBITDA and liquidity figures, which are direct inputs to valuation and positioning.

Market effects

Power generation and retail utilities may see read-through on demand resilience and hedging effectiveness, but the article is single-company focused.

Primarily US-listed utility/energy market sentiment; limited direct regional spillover described.

No explicit global macro or cross-border catalyst beyond commodity-market volatility management.

Counterpoint

Non-GAAP results are influenced by unrealized hedging gains that settle later, so the market may discount guidance quality if cash conversion disappoints.

Key entities

  • Vistra

    Reported Q3 2026 results and issued updated 2026 guidance plus initial 2027 adjusted EBITDA guidance.

Related articles

$VSTHighAI 8/10

VST Q3 Earnings Beat on Strong Power Pricing, Revenues Rise Y/Y

Vistra Corp. reported Q3 2026 earnings of $3.23 per share, beating estimates by 9.86%. Revenues rose 27.7% YoY to $6.35B. Higher energy prices and acquisitions supported results. Adjusted EBITDA increased 50.4% to $2.38B. The company raised 2026 guidance and initiated 2027 outlook, including Cogentrix acquisition impacts.

$CEGHighAI 8/10

Constellation CEO Sounds the Alarm: Data Center Demand Was a “Massive Overestimation.” Its Nuclear Contracts Run to the 2040s

Constellation Energy CEO Joe Dominguez stated that data center demand was overestimated, impacting grid projects. The company raised 2026 EPS guidance to $12.50-$12.80. Analysts expect EPS to rise from $9.39 in 2025 to $16.80 in 2028. Constellation has secured long-term contracts, including deals with Google and Amazon, mitigating demand risks.

$VSTMedAI 8/10

Vistra Q3 Earnings Call Highlights Cash Flow Plans & Demand Risks

Vistra Corp. reported Q3 2026 earnings of $3.23 per share, beating estimates, but revenues of $6.35B missed expectations. The company raised its 2026 and 2027 adjusted EBITDA and free cash flow guidance. Management discussed growth plans, including acquisitions like Cogentrix, and addressed regulatory uncertainties in Texas and PJM.